https://emerge.compugen.com/emerge/enterprise/Login
Compugen Emerge
compugenemerge
https://www.fool.com/earnings/call-transcripts/2021/05/13/compugen-ltd-cgen-q1-2021-earnings-call-transcript/
Compugen Ltd. (CGEN) Q1 2021 Earnings Call Transcript | The Motley Fool
May 14, 2021 - CGEN earnings call for the period ending March 31, 2021.
earnings call transcriptcompugen ltdq1 2021the motleycgen
https://www.biospace.com/compugen-reports-first-quarter-2024-results
Compugen Reports First Quarter 2024 Results - BioSpace
May 20, 2024 - Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced...
first quarter2024 resultscompugenreports
https://www.compugen.us/
IT + Service Delivery | Compugen Systems Inc.
Compugen Systems Inc is an IT + service delivery company redefining the customer experience into uniquely crafted human experiences; see how:
it service deliverycompugensystemsinc
https://www.macrotrends.net/stocks/charts/CGEN/compugen/return-on-tangible-equity
Compugen Return on Tangible Equity 2012-2025 | CGEN | MacroTrends
Current and historical return on tangible equity values for Compugen (CGEN) over the last 10 years. Return on tangible equity can be defined as the amount of...
return on tangible equitycompugen20122025cgen
https://www.compugen.com/
IT Solution Provider | Compugen Inc
Compugen, one of Canada's largest privately-owned and operated IT service providers, helps organizations realize new possibilities. Start now:
it solutionprovidercompugeninc
https://www.home.saxo/pl-pl/markets/stocks/cgen-xnas
Compugen Ltd akcja | Saxo Bank
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to...
compugen ltdakcjasaxobank
https://www.fool.com/investing/2021/05/13/why-compugen-stock-is-jumping-today/
Why Compugen Stock Is Jumping Today | The Motley Fool
May 13, 2021 - Investors liked what the company had to say in its Q1 update.
the motleycompugenstockjumpingtoday
https://www.calcalistech.com/ctechnews/article/b1ue00g1wa
Compugen shares soar on massive deal with Gilead, worth up to $848 million | Ctech
Dec 19, 2023 - The Israeli company utilizes its broadly applicable predictive computational discovery capabilities to identify new drug targets and biological pathways for...
https://www.macrotrends.net/stocks/charts/CGEN/compugen/ebitda
Compugen EBITDA 2012-2025 | CGEN | MacroTrends
Compugen ebitda from 2012 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
compugenebitda20122025cgen
https://www.prnewswire.com/il/news-releases/compugen-to-release-first-quarter-2025-results-on-monday-may-19-2025-302445841.html
Compugen to Release First Quarter 2025 Results on Monday, May 19, 2025
/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery,...
first quarter2025 resultson mondaycompugenrelease
https://www.prnewswire.com/il/news-releases/compugen-to-release-second-quarter-2024-results-on-tuesday-august-6-2024-302203750.html
Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024
/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery,...
second quarter2024 resultscompugenrelease
https://www.home.saxo/fr-be/markets/stocks/cgen-xnas
Compugen Ltd action | Saxo Bank
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to...
compugen ltdactionsaxobank
https://www.prnewswire.com/news-releases/compugen-to-present-pooled-analysis-of-com701-in-three-phase-1-trials-in-patients-with-platinum-resistant-ovarian-cancer-at-esmo-2025-302581918.html
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum...
/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target...
https://www.biospace.com/compugen-to-receive-milestone-payment-triggered-by-dosing-of-first-patient-in-the-second-phase-3-trial-evaluating-rilvegostomig
Compugen to Receive Milestone Payment Triggered by Dosing of First Patient in the Second Phase 3...
May 30, 2024 - Compugen Ltd. today announced it is entitled to receive a milestone payment from AstraZeneca (LSE/STO/Nasdaq: AZN) triggered by the dosing of the first patient...
https://www.calcalistech.com/ctech/articles/0,7340,L-3735453,00.html
AstraZeneca Signs Deal with Cancer Immunotherapy Company Compugen - CTech
Apr 3, 2018 - The deal has the potential to be worth over $200 million for Nasdaq-listed Compugen
cancer immunotherapyastrazenecasignsdealcompany
https://www.biospace.com/compugen-to-participate-in-two-upcoming-april-2024-investor-conferences
Compugen to Participate in Two Upcoming April 2024 Investor Conferences - BioSpace
Apr 3, 2024 - Compugen Ltd. a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced that management will participate in the...
to participatein twoapril 2024investor conferencescompugen
https://www.fool.com/investing/2022/11/30/why-shares-of-compugen-rose-165-on-wednesday/
Why Shares of Compugen Rose 16.5% on Wednesday | The Motley Fool
Nov 30, 2022 - Market factors and a company announcement helped the stock climb.
16 5
https://campus.compugen.com/
Compugen Campus
Campus Compugen offers educational training activities for iPad, Apple, Google, Jamf, Promethean and Microsoft.
compugencampus
https://www.biospace.com/compugen-to-host-conference-call-to-discuss-exclusive-license-agreement-with-gilead-for-com503-novel-immuno-oncology-pre-clinical-program-harnessing-il-18-biology
Compugen to Host Conference Call to Discuss Exclusive License Agreement with Gilead for COM503,...
Dec 20, 2023 - Compugen Ltd. today announced that it will host a conference call at 8:30 AM ET today, to discuss the exclusive license agreement with Gilead announced today,...
exclusive license agreement
https://www.trendmicro.com/pt_br/about/human-connections/compugen.html
Compugen | Trend Micro (BR)
trend microcompugenbr
https://www.crn.com/news/channel-news/compugen-ceo-zarek-on-hybrid-work-xaas-plans-and-tackling-cloud-opportunity
Compugen CEO Zarek On Hybrid Work, XaaS Plans And Tackling Cloud Opportunity | CRN
Compugen CEO and IT veteran Zarek talks cloud, pandemic, and new opportunities for 2023.
https://finviz.com/news/343395/compugen-to-participate-in-25th-annual-needham-virtual-healthcare-conference
Compugen to Participate in 25th Annual Needham Virtual Healthcare Conference
Stock screener for investors and traders, financial visualizations.
to participatevirtual healthcarecompugen25thannual
https://www.biospace.com/compugen-s-com701-anti-pvrig-demonstrates-preliminary-durable-anti-tumor-activity-in-triple-immunotherapy-combination-in-patients-with-recurrent-metastatic-mss-endometrial-cancer
Compugen's COM701 (anti-PVRIG) Demonstrates Preliminary Durable Anti-Tumor Activity in Triple...
Jun 5, 2023 - Compugen Ltd. today announced data to be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, showing that Compugen's COM701...
https://www.prnewswire.com/news-releases/compugen-to-participate-in-the-jmp-securities-hematology-and-oncology-summit-301688631.html
Compugen to Participate in the JMP Securities Hematology and Oncology Summit
/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today...
hematology and oncologyparticipate incompugen